Washington, D.C- Energy and Commerce Republican Leader Cathy McMorris Rodgers (R-WA) and Energy and Commerce Health Subcommittee Republican Leader Brett Guthrie (R-KY) released the following statement after the House passed a series of bipartisan health bills this week:
“We applaud all our colleagues for working in an overwhelming bipartisan way to pass these solutions to improve the health and wellness of all Americans. All of these bills deserve to be sent to the president’s desk to help lower the costs of prescription drugs, expand research into minority health disparities, support funding for lifesaving transplants to treat diseases like blood cancers and sickle cell anemia, and also protect the most vulnerable from bad actors distributing controlled substances. We’re grateful for all our colleagues, including Reps. Bob Latta, Morgan Griffith, Buddy Carter, Bill Johnson, and Richard Hudson, and Chris Smith who plowed the hard ground of building strong bipartisan support on their bills for final passage the People’s House."
The House passed the following bills:
* To amend the Federal Food, Drug, and Cosmetic Act (with respect to the scope of new chemical exclusivity (S. 415)
* Ensuring Compliance Against Drug Diversion Act of 2021 (H.R. 1899)
* DEBAR Act of 2021, as amended (H.R. 1002)
* TRANSPLANT Act of 2021 (H.R. 941)
* United States Anti-Doping Agency Reauthorization Act of 2021 (H.R. 172)
* Advancing Education on Biosimilars Act of 2021 (S. 164)
* FASTER Act of 2021 (H.R. 1202)
* John Lewis NIMHD Research Endowment Revitalization Act of 2021 (H.R. 189)
